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Introduction: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare, newly defined autoimmune
clinical entity that presents with atypical clinical manifestations. Most patients with anti-N-methyl-D-aspartate
receptor encephalitis develop a progressive illness from psychosis into a state of unresponsiveness, with catatonic
features often associated with abnormal movements and autonomic instability. This is the first report of
anti-N-methyl-D-aspartate receptor encephalitis in a Greek pediatric hospital.
Case presentation: An 11-year-old Greek girl presented with clinical manifestations of acute psychosis. The
differential diagnosis included viral encephalitis. The presence of a tumor usually an ovarian teratoma, a common
clinical finding in many patients, was excluded. Early diagnosis and prompt immunotherapy resulted in full recovery
up to one year after the initial diagnosis.
Conclusion: Acute psychosis is a rare psychiatric presentation in children, diagnosed only after possible organic
syndromes that mimic acute psychosis are excluded, including anti-N-methyl-D-aspartate receptor receptor
encephalitis. Pediatricians, neurologists and psychiatrists should consider this rare clinical syndrome, in order to
make an early diagnosis and instigate appropriate treatment to maximize neurological recovery.
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Anti-N-methyl-D-aspartate receptor (anti-NMDAR) en-
cephalitis belongs to the autoimmune and paraneoplastic
encephalitides [1]. Initial reports of a syndrome charac-
terized by psychiatric manifestations, memory loss, de-
creased consciousness, and hypoventilation in four young
women with ovarian teratomas were published in 2005
[2]. In 2007, auto-antibodies against the NMDAR were
detected in these women and eight others with similar
symptoms, seven of whom also had ovarian teratomas
[2]. Most patients exhibit psychosis, memory loss, sei-
zures, and language disintegration, and may develop* Correspondence: vivian.maggina@hotmail.com
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reproduction in any medium, provided the orunresponsiveness with catatonic features or periods char-
acterized by abnormal movements, including autonomic
and breathing instability [2]. Anti-NMDAR encephalitis
mainly affects children and young adults and may be
associated with malignancy. The presence of a tumor
(usually an ovarian teratoma) is dependent on age, gender,
and ethnicity, and is associated with a better prognosis
after tumor resection and immunotherapy (corticoster-
oids, intravenous immunoglobulin, plasma exchange)
than in patients who do not have tumors. More than 75%
of all patients recover in association with declining
antibody titers but relapses are frequent and a close
follow-up is necessary, at least for two years, after ini-
tial diagnosis [2].
In this report, we present a case of anti-NMDAR en-
cephalitis that was diagnosed in an 11-year-old Greek
girl who presented with subacute encephalopathy andal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nancy. To the best of our knowledge, this is the first
pediatric patient diagnosed with anti-NMDAR encephal-
itis in Greece.
Case presentation
A previously healthy 11-year-old girl with alternating
confusion and agitation was admitted to the emergency
department. She had a three day history of headaches,
nausea, and sleepiness, 12 days prior to presentation at
the hospital. Behavioral changes included low school
performance, reduced food intake, troubled sleep, exces-
sive and unintelligible speech referring mainly to her
clothes, and panic possibly due to visual hallucinations,
which intensified the day before admission. One week
earlier, cranial magnetic resonance imaging (MRI) at an-
other hospital was normal and she was diagnosed with
an acute psychotic episode and prescribed olanzapine.
Neurological examination on admission noted stupor
with agitation, fluctuation in consciousness with loss of
ability to speak or make eye contact, limb dyskinesias,
urinary incontinence, and self-harming behaviour (bit-
ing lips, knocking her head and her arms on the bed)
(Table 1). The first days of hospitalization featured
short periods of appropriate communication interrupted
by behaviour indicating visual and auditory hallucina-
tions. More frequent and intense episodes of agitation
were followed by extrapyramidal signs and symptoms,
including dystonia of the left leg and lower jaw move-
ments, rhythmic tongue thrusting, chewing movements,
teeth grinding, and lip biting. Seizures, mainly focal
right or left sided convulsions were noted. Some of these
episodes featured a truncal urticaria-like rash that
receded in a few minutes and mild pyrexia (37 to
37.7oC). She was hemodynamically stable, with normal
respiratory function.
Extensive investigations for metabolic, infectious, toxic,
autoimmune, central nervous system and psychiatric dis-
orders were performed. An electroencephalogram (EEG)
demonstrated right-side slowing without epileptiform
discharges. Cranial MRI was normal. Her cerebrospinal
fluid (CSF) examination was normal including polymer-
ase chain reaction (PCR) for herpes simplex viruses
(HSV-1,2) and negative serology for viruses (adenovirus,
enterovirus, cytomegalovirus, measles and rubella), toxo-
plasma, and mycoplasma, but oligoclonal bands were
demonstrated. Toxicology tests on blood and urine were
negative. No evidence was found for possible metabolic
causes, including Wilson’s disease and porphyria. Thy-
roid function was normal. Negative anti-nuclear anti-
bodies, antiphospholipid antibody, normal titer of anti-
deoxyribonucleic acid (DNA) antibody to native DNA
and absence of antibody to Sm nuclear antigen excluded
systemic lupus erythematosus. Serum immunoglobulinM (IgM) for human herpes virus 1, 2, 6, Epstein-Barr
virus, cytomegalovirus, enterovirus, adenovirus, measles,
mumps, rubella, chickenpox, parvovirus B19, borrelia,
mycoplasma and toxoplasma was negative. Anti-
NMDAR antibodies were revealed on immunohisto-
chemistry in her serum and CSF. The association of anti-
NMDAR antibodies with ovarian teratoma and other ab-
dominal and thoracic tumors prompted pelvic ultra-
sonography, abdominal MRI and thoracic X-ray
computed tomography (CT), all of which were normal.
Testing for related tumor markers (alpha-fetal protein
[α-FP], and human chorionic gonadotropin [β-hCG]) was
negative.
Initial intervention was mostly symptomatic treatment
of acute psychosis including diazepam (5–7.5mg/day
IV), fluoxetine (10mg/day orally), risperidone (0.5mg or-
ally 3 times per day) and biperiden (2mg orally 1 to 2
times per day). During severe episodes of agitation, she
received midazolam (0.1mg/kg/dose IV).
Anti-NMDAR encephalitis was diagnosed 16 days after
admission, and intravenous immunoglobulin (0.4g/kg
every 24 hours for five days) and pulses of methylpredni-
solone (30mg/kg for five doses) were administered fol-
lowed by oral prednisolone with progressive tapering of
the dose. She also received three pulses of cyclophospha-
mide (750mg/m2), the first pulse 32 days after admis-
sion, and then at monthly intervals.
Symptoms improved following immunotherapy with
steroids and intravenous immunoglobulin, and the fre-
quency and duration of episodes of agitation and dys-
tonia declined. The need for sedation medication
(midazolam intravenous) was substantially reduced and
discontinued after the last episode of agitation, on day
33. Fluoxetine was discontinued after the diagnosis of
anti-NMDAR encephalitis; risperidone and diazepam
were gradually withdrawn four weeks later. Communica-
tion and mobility improved 15 days after the administra-
tion of the first pulse of cyclophosphamide, and she was
discharged on day 71 with mild dystonic gait and signifi-
cant psychiatric manifestations; her verbal communica-
tion was poor, she had recent memory deficits, but she
was able to read and make simple calculations. She
demonstrated progressive improvement of cognitive and
motor neurological functions over the next six months.
She recovered fully and returned to school without ap-
parent cognitive or behavioral problems after one year.
Repeat testing for anti-NMDAR antibodies in her blood,
five months after diagnosis, was negative and the EEG
results were normal.
Discussion
This clinical case presentation with symptoms resembling
acute psychosis is consistent with the diagnosis of anti-
NMDAR encephalitis, an autoimmune disorder described
Table 1 Patient’s characteristics and clinical































Substantial improvement/Full recovery yes
CSF cerebrospinal fluid, EEG electroencephalography, IVIG intravenous
immunoglobulin, WBC white blood cells, MRI magnetic resonance imaging.
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The autoimmune pathogenesis [5] is mediated by anti-
bodies, detected in serum and CSF, that mainly target the
NR1 subunit of the NMDA receptor on the cell surface
of neurons [3,6].
It has been demonstrated that this disorder is more
frequent in children than previously thought, and that
clinical manifestations in pediatric patients are similar to
those of adults [7]. Prodromal symptoms such as low
fever, headache, common cold-like symptoms, and gastro-
enteritis are found in most cases. The most frequent clin-
ical presentation resembles acute psychosis [5] (anxiety,
agitation, paranoia, visual and auditory hallucinations),
but recognizing such symptoms in young children may
be difficult. Dystonia and dyskinesias, abnormal move-
ments of the face, tongue, limbs, trunk, and abdomen arecommon. Seizures can be noted although not demon-
strated by EEG and there must be caution about any
excessive use of antiepileptic drugs in these patients. Au-
tonomic manifestations such as urinary incontinence and
sleep dysfunction are common. However, more severe
autonomic dysregulation such as central hypoventilation,
dysrhythmia, tachycardia, and hyperthermia is rarely
seen in children.
In children the frequency of teratoma [3] is low
compared to that in adults. However, some tumors
are detected many months after the initial encephalitic
episode. Since some investigations have age-related
limitations, all patients should undergo ultrasound and
MRI of the abdomen and pelvis at initial diagnosis, as
well as periodically for at least two years after the
first episode.
Treatment includes surgical removal of ovarian tera-
toma or other tumors and prompt and aggressive im-
munotherapy [2,8]. Some children appear to respond
rapidly to intravenous immunoglobulin and methylpred-
nisolone but may exhibit slow improvement independent
of the treatment used. Other therapeutic options include
cyclophosphamide, anti-CD20 monoclonal antibodies
(rituximab), and plasma exchange, mainly in more se-
vere/persistent cases. Studies published to date indicate a
favorable prognosis for most young patients (75% re-
spond to initial treatment, 29% recover fully, 45% im-
prove significantly, and 26% reveal minor improvement)
[7]. The outcome improves following removal of a tera-
toma, if present, in combination with immunotherapy
[9,10]. Relapses have been noted in approximately 25% of
young patients and seem to occur while tapering im-
munotherapy, as well as in cases without teratoma in
those with high titers of anti-NMDAR antibodies in the
CSF. Follow-up evaluation [7] should include neurologic
and psychiatric examinations, ultrasound and MRI of the
pelvis and abdomen, and measurements of the levels of
anti-NMDAR antibodies’ titers in serum and CSF.
Conclusion
The diagnosis of ‘acute psychosis’ in children is rare and
can be made only after possible organic causes are
excluded. The differential diagnosis is broad, with viral
encephalitis being the most likely alternative cause in
these circumstances. Anti-NMDAR encephalitis is a new
autoimmune disorder that commonly presents with psy-
chiatric manifestations. Pediatricians, neurologists and
psychiatrists should be aware of this disease’s clinical
spectrum to identify and properly treat these patients.
Once specific anti-NMDAR antibodies are detected, it
is crucial to start correct treatment, including tumor re-
moval and intense immunotherapy, immediately. This
disease has a good prognosis in the majority of cases if
diagnosed early and treated properly.
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